Skip to main content


Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

Fig. 1

Intraarticular injection of tranexamic acid after capsule closure. After watertight capsule closure, a solution of 1 g tranexamic acid in 50 mL normal saline was injected intraarticularly into the knee joint. Leakage of the solution was further monitored through the range of motion. Note the clamped drainage tube

Back to article page